Dr. Goicoechea is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10666 N Torrey Pines Rd
Mail Drop 201n
La Jolla, CA 92037Phone+1 858-554-9100
Education & Training
University of California (San Diego) Medical CenterFellowship, Infectious Disease, 2002 - 2005
Mount Sinai Medical Center of FloridaResidency, Internal Medicine, 1998 - 2001
Howard University College of MedicineClass of 1998
Certifications & Licensure
CA State Medical License 2002 - 2025
FL State Medical License 2001 - 2005- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Top Doctors:San Diego Area Castle Connolly, 2013
- Top Doctors:Southern California Castle Connolly, 2012
Clinical Trials
- CCR5 Inhibitor Treatment Intensification on CD4+ T-cell Recovery Start of enrollment: 2008 Oct 20
Publications & Presentations
PubMed
- 235 citationsGreater Tenofovir-Associated Renal Function Decline with Protease Inhibitor-Based versus Nonnucleoside Reverse-Transcriptase Inhibitor-Based TherapyMiguel Goicoechea, Shanshan Liu, Brookie M. Best, Shelly Sun, Sonia Jain
The Journal of Infectious Diseases. 2008-01-01 - 11 citationsAbacavir and increased risk of myocardial infarctionMiguel Goicoechea, Allen McCutchan
Lancet. 2008-09-06 - 38 citationsEfavirenz--still first-line king?Brookie M. Best, Miguel Goicoechea
Expert Opinion on Drug Metabolism & Toxicology. 2008-07-15
Grant Support
- Pharmacokinetics And Pathogenesis Of Treatment ResponsesNational Institute Of Allergy And Infectious Diseases2007–2010
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
